HIF1A and myeloid sarcoma: Moreover, we also examined the mRNA level of HIF1A in peripheral blood leukocytes of healthy control and MS patients and found a significant increase of HIF1A in MS patients (Fig. 5M) and a positive correlation between HIF1A expression level and EDSS scores (Fig. 5N).